This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The Catholic University of Korea. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Sun Woo Lim: Innovator in Immunology
Introduction
Sun Woo Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in developing compositions that alleviate nephrotoxicity caused by immunosuppressive drugs. His innovative work aims to improve treatment outcomes for patients requiring immunosuppression.
Latest Patents
Sun Woo Lim holds a patent for a composition designed to alleviate nephrotoxicity caused by immunosuppressive drugs, which includes metformin. This composition is also aimed at preventing or treating immune diseases. The invention provides a method to improve treatment effects on diseases that require immunosuppression by effectively mitigating the decline in renal function associated with conventional immunosuppressive drugs. Furthermore, it suggests various methods of co-administering conventional immunosuppressive drugs and metformin to reduce nephrotoxic side effects while maximizing immunosuppressive or immunomodulatory effects. He has 1 patent to his name.
Career Highlights
Sun Woo Lim is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His work at this institution has allowed him to engage in cutting-edge research and development in the field of immunology.
Collaborations
Some of his notable coworkers include Mi La Cho and Chul Woo Yang. Their collaborative efforts contribute to the advancement of research in immunology and related fields.
Conclusion
Sun Woo Lim is a dedicated inventor whose work has the potential to significantly impact the treatment of immune diseases and improve patient outcomes. His innovative compositions represent a meaningful advancement in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile